Pfizer has entered into an exclusive Supply and Marketing Agreement with Cipla for marketing and distribution of four brands of the Company, viz., Corex Dx, Corex LS, Dolonex, and Neksium for an initial period of 5 years.Powered by Capital Market - Live News

Net profit of Pfizer rose 19.37% to Rs 189.02 crore in the quarter ended September 2025 as against Rs 158.35 crore during the previous quarter ended September 2024. Sales rose 9.13% to Rs 642.34 crore in the quarter ended September 2025 as against Rs 588.59 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales642.34588.59 9 OPM %35.8032.15 - PBDT269.65230.22 17 PBT255.37215.23 19 NP189.02158.35 19 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Net profit of Pfizer rose 27.23% to Rs 191.75 crore in the quarter ended June 2025 as against Rs 150.71 crore during the previous quarter ended June 2024. Sales rose 7.14% to Rs 603.05 crore in the quarter ended June 2025 as against Rs 562.86 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales603.05562.86 7 OPM %34.8331.53 - PBDT273.94217.22 26 PBT259.53202.62 28 NP191.75150.71 27 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News